3rd Annual Drug Discovery Chemistry Conference

3rd Annual Drug Discovery Chemistry Conference is organized by SMi Group Ltd and will be held from Mar 18 - 19, 2019 at Copthorne Tara Hotel London Kensington, London, England, United Kingdom.

The target audience for this medical event is CEOs, Presidents, Vice Presidents and Global Heads, Executive Directors, Vice President and Global head, Principal Scientists, Heads of Business Development, Directors of Pharma/Biotech firms.

The drug discovery field is undergoing dramatic change. There is currently a reduced output of new medicines due to challenges in R&D, pricing pressures and regulations. While these challenges are slowing progress, demand for new, more effective medicines are steadily growing. However, new technologies have allowed for the drug discovery process to overall become more streamlined and cost-efficient, and scientific advances have made the identification of novel drug targets, modalities, and therapeutic areas to be recognised. This presents a new opportunity for the development of novel medicines and technologies within the pharmaceutical market.

Chaired By: Roderick Hubbard, Senior Fellow, Vernalis Research Ltd and Darren Green, Director of Molecular Design, GSK

This year's event will specifically focus on innovations within the field that has the potential to drive the pharmaceutical industry into a new era of medicines, with optimisation of the RandD process to become cheaper, faster and increasing the likelihood of drug efficacy and success. These are some of the major obstacles within drug discovery, as the process is overall long, expensive and often potential drugs will fail late in clinical trials.

The event will also focus on novel techniques that can be implemented within the field today that identify new druggable targets and possibly open new therapeutic areas within clinic and also look at various developments within the field, guiding companies on how they can best utilise the newest technologies and drug discovery modalities to develop new medicines, reduce their RandD cost, timelines, and ultimately, increase their medicine output for commercial success.

Key Topics Include:
• Discuss the impact of the use of novel computational techniques on Rand pipelines
• Hear about the progress in the development of new drugs on difficult targets and how these can revolutionise patient treatment
• Discover how AI is being utilised in the commercial setting and opportunities to best exploit these to streamline via Drug Discovery Process
• Explore the potential of new modalities to transform therapeutics
• Learn about current strategies to increase drug discovery success

Benefits of Attending :
• Discuss latest advances in medicinal chemistry techniques and how these can be implemented in the commercial space of drug discovery.
• Learn about protein degradation in drug discovery with the utilisation of PROTACs
• Hear about PPIs and how protein-protein interactions are being targeted in drug discovery
• Gain insight into the potential of Macrocycles in targeting difficult genomic targets 
• Discuss the uses and advances in AI in drug discovery and the potential for the future
• Hear about how the pharmaceutical industry are making use of AI currently

Post Conference Workshop 20 March 2019 - Artificial Intelligence in Drug Discovery - Led by: Nick Camp, Consultant

Time: 8:30 am - 5:10 pm